Camber Pharmaceuticals is proud to have been named a Second Merit Finalist for the 2026 Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2026 HDA Business and Leadership Conference.
This recognition reflects Camber Pharmaceuticals’ ongoing commitment to delivering high-quality, affordable medicines while fostering strong, collaborative relationships across the healthcare supply chain. Camber works closely with its distributor partners to improve operational efficiency, ensure reliable product availability, and support patient access to essential medications.
“We are honored to be recognized as a Second Merit Finalist for the DIANA Award,” Scott Hettenhausen, VP Rx Sales. “This achievement is a testament to the dedication of our team and the strength of our partnerships throughout the healthcare distribution industry. Together, we remain focused on advancing innovative solutions that help improve access to affordable healthcare for patients nationwide.”
Established in 1959, the DIANA Award is one of HDA’s highest honors, recognizing healthcare manufacturers that demonstrate exceptional leadership, innovation, and collaboration in advancing the healthcare supply chain.
